Clinical trial
A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in…
NCT00106509 · Genzyme, a Sanofi Company, Industry · Completed
Key facts
| NCT number | NCT00106509 |
|---|---|
| Title | A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C.Difficile - Associated Diarrhea |
| Official title | A Randomized, Double-Blind Study of GT267-004 Versus Vancomycin, and GT267-004 Versus Metronidazole, in Patients With C.Difficile - Associated Diarrhea |
| Lead sponsor | Genzyme, a Sanofi Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Clostridium Enterocolitis, Pseudomembranous Colitis |
| Intervention type | Drug |
| Interventions | tolevamer potassium-sodium (GT267-004) |
| Enrollment | 520 |
| Start date | Mar 1, 2005 |
| Completion | Feb 1, 2007 |
| First posted | Mar 28, 2005 |
| Last update posted | Mar 5, 2015 |
| Countries | Canada, Puerto Rico, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: